For example, steroid receptor activation in breast cancer cell lines induces FOXA1 recruitment to sites with degenerate FOXA1-binding motifs18,20, exemplifying heterogeneity in FOXA target site engagement. This evidence concerns the gene FOXA1 and breast carcinoma.